时间：2023-12-11 01:58:24 来源：网络整理 编辑：스포츠
Daewoong Pharmaceutical said Tuesday that its botulinum toxin product, Nabota, posted 113.3 billion
Daewoong Pharmaceutical said Tuesday that its botulinum toxin product, Nabota, posted 113.3 billion won ($85.3 million) in sales as of the third quarter this year.
Overseas sales made up 93.5 billion won or 83 percent of the total, the company added.
Nabota's overseas sales have continued growing in recent years, an outcome of Daewoon's global push. The portion reached 61 percent in 2021 and then surged to 77 percent last year.
US sales, in particular, reached 44.5 billion won, making up more than 50 percent of global sales.
“Nabota’s share in the US botulinum toxin market has surged over the last two years. We expect to further boost our share in the future," a Daewoong official said.
Nabota, sold as Jeuveau in the US, made its US debut in 2020 through local partner Evolus’ botulinum toxin treatment program. Nabota currently has around an 11 percent share in the US botulinum toxin market, according to the company.
“Nabota was able to take the lead among Korea’s botulinum toxin products as Daewoong set its plans ahead for its launch in the US and received approval from the US Food and Drug Administration fast,” said Park Seong-soo, vice president of Daewoong Pharmaceutical.
In South Korea, a total of 11 botulinum toxin products have received approval from the government so far, and three additional products are under review.
Daewoong said the company will speed up Nabota launches in European countries, including Germany, Italy and Austria.
The company added it would also make a foray into the Malaysian market soon. In August, Daewoong received sales approval from the National Pharmaceutical Regulatory Agency in Malaysia.
12일부터 4·10총선 예비후보자 등록 시작2023-12-11 01:37
AliExpress vows to invest W10b to root out fake goods in Korea2023-12-11 01:24
Samsung SDI renews push for all2023-12-11 01:10
LG wins SOAFEE board membership to join Arm, Bosch2023-12-11 00:38
Actors, musicians unite for Hakchon Theater's closing act2023-12-10 23:43
LG wins SOAFEE board membership to join Arm, Bosch2023-12-10 23:37
Drug offences rise by nearly 50 percent on2023-12-10 23:31
BMW, Mercedes2023-12-10 23:28
BMW, Mercedes2023-12-11 01:44
Court overturns ruling on fabricated asylum interview: report2023-12-11 01:39
LG Display to cut jobs in cost2023-12-11 01:31
Tourism potential of Philippines, Korea discussed at GBF2023-12-11 01:21
BTS' V and Blackpink's Jennie break up: sources2023-12-11 01:20
Seoul shares edge down amid US slowdown woes; won sharply down2023-12-10 23:41
Four Korean drama series nominated for Critics Choice Awards2023-12-10 23:28
Seoul stocks end nearly flat on cautious note2023-12-10 23:18